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Abstract
Introduction: Recent studies have shown that apoptosis plays a critical role in the pathogenesis of sepsis. High plasma cell
free DNA (cf-DNA) concentrations have been shown to be associated with sepsis outcome. The origin of cf-DNA is unclear.
Methods: Total plasma cf-DNA was quantified directly in plasma and the amplifiable cf-DNA assessed using quantitative
PCR in 132 patients with bacteremia caused by Staphylococcus aureus, Streptococcus pneumoniae, ß-hemolytic
streptococcae or Escherichia coli. The quality of cf-DNA was analyzed with a DNA Chip assay performed on 8 survivors
and 8 nonsurvivors. Values were measured on days 1–4 after positive blood culture, on day 5–17 and on recovery.
Results: The maximum cf-DNA values on days 1–4 (n=132) were markedly higher in nonsurvivors compared to survivors
(2.03 vs 1.26 ug/ml, p,0.001) and the AUCROC in the prediction of case fatality was 0.81 (95% CI 0.69–0.94). cf-DNA at a cut-
off level of 1.52 ug/ml showed 83% sensitivity and 79% specificity for fatal disease. High cf-DNA (.1.52 ug/ml) remained an
independent risk factor for case fatality in a logistic regression model. Qualitative analysis of cf-DNA showed that cf-DNA
displayed a predominating low-molecular-weight cf-DNA band (150–200 bp) in nonsurvivors, corresponding to the size of
the apoptotic nucleosomal DNA. cf-DNA concentration showed a significant positive correlation with visually graded
apoptotic band intensity (R=0.822, p,0.001).
Conclusions: Plasma cf-DNA concentration proved to be a specific independent prognostic biomarker in bacteremia. cf-
DNA displayed a predominating low-molecular-weight cf-DNA band in nonsurvivors corresponding to the size of apoptotic
nucleosomal DNA.
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Introduction
Bacteremia and sepsis are major causes of death worldwide.
Despite intensive research, there are significant gaps in our
knowledge regarding the basic pathophysiological mechanisms
associated with fatal outcome. This hampers attempts to develop
novel therapeutic interventions for this condition.
Several studies indicate that most deaths from bacteremia and
sepsis are in fact the result of a substantially impaired immune
response due to the extensive death of immune system cells [1].
Studies during recent years have shown that immunosupression
plays a pivotal role in severe sepsis [2,3]. The term septic
immunoparalysis has been introduced [1,2]. In clinical practice,
patients with severe sepsis evince an inability to overcome initial
infections and are prone to secondary hospital-acquired infections,
i.e. fungal, viral and bacterial infections. Lymphocyte apoptosis,
T cell anergy, decreased antigen presentation and decreased
HLA-DR expression are features associated with the condition [1].
Apoptosis is an active suicidal cellular response involved in the
homeostasis of cell removal under physiologic and pathologic
conditions [4,5]. It has even been debated whether immunosu-
pression and lymphocyte apoptosis constitute rather a primary
than a secondary phenomenon during severe sepsis [3]. Monitor-
ing apoptosis on a routine basis in septic patients has been found
challenging and indirect markers of apoptosis (e.g. sFas) have
proved to be of limited value [4].
Circulating cell-free DNA (cf-DNA) has recently received
growing attention and has been studied in various acute and
chronic disorders. High cf-DNA levels have been reported in
cancer [6], rheumatoid arthritis [7], stroke [8], and sepsis [9,10]
and has also been proposed as a prognostic marker in these
conditions. One recent study showed increased cf-DNA concen-
trations in agetarians [11]. Studies in sepsis patients indicate that
plasma DNA and nucleosome levels are elevated in sepsis patients
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e21700with poor outcome [5,9]. cf-DNA has been shown to predict
infection [12] and in-hospital mortality in critically ill patients
[10,13]. In healthy individuals, the concentration of circulating
DNA is low, as dead cells are efficiently removed from the
circulation by phagocytes. Circulating DNA has a short half-life
and is removed mainly by the liver. Excessive accumulation of
DNA in the plasma may result from the release of DNA caused by
massive cell death, inefficient removal of dying cells or a
combination of both [5].
Although plasma cf-DNA in bacteremia and sepsis has been
thought to be a product of accelerated cell death, the precise
mechanisminsepticpatientsremainselusive.Wemeasuredcf-DNA
levels directly in plasma, quantified both total and amplifiable cf-
DNA, and finally carried out a qualitative analysis of cf-DNA with a
high-sensitivity lab-on-a-chip DNA assay. The results show that
plasma cell free DNA (cf-DNA) is elevated in bacteremic patients
with poor outcome. We demonstrate that nonsurvivors express
markedly increased apoptotic DNA fragmentation. The findings
presented provide novel insights into the basic pathophysiological
mechanisms of a severe bacteremic infection.
Materials and Methods
The study material comprised 132 adult patients with bacteremia
admitted to Tampere University Hospital, Tampere, Finland, from
June 1999 to February 2004 (Table 1). Patient recruitment, clinical
data collection and sample collection were prospective. Samples for
cf-DNA were analyzed after hospitalization.
In our hospital blood cultures are routinely taken in cases with
symptoms or signs of systemic infection (fever or hypothermia,
tachycardia or tachypnea combined with leucocytosis or leucope-
nia and/or elevated C-reactive protein (CRP)). The BACTEC
9240 (BD Diagnostic Systems, Sparks, MD, USA) blood culture
system was used with standard media. Patients were identified
according to microbiological blood culture finding, and only those
with bacteremia caused by S. aureus, Str. pneumoniae, ß-hemolytic
streptococcus or E. coli, the most common causative organisms in
community-acquired bacteremia, were included in the study, other
microbes being excluded beforehand. Blood culture-negative
patients with or without sepsis syndrome and those not consenting
were not included. All patients included in the study had verified
infection. Only patients at least 16 years of age were enrolled. The
clinicians ( J.S. or J.L.) were informed by the clinical microbiologist
(R.V.) of a positive blood culture from Mondays to Thursdays and
the patients were enrolled in the study whenever possible to adjust
to the daily schedule. We were able to recruit zero to two patients
per week during the study period. Since the clinicians had no
knowledge of details regarding the patients or their disease severity
prior to recruitment, selection was based solely on the blood
culture finding. Upon notification by the clinical microbiologist the
clinicians ( J.L. and J.S.) asked patients to participate and
interviewed and examined those consenting. Information was
gathered from hospital records at the time of a hospital visit and
hospital records were also reviewed subsequent to hospitalization
(R.H.). Altogether 149 out of 152 patients agreed to participate.
Samples for cf-DNA determinations during 1–4 days after positive
blood culture were available in 132 patients, and these were
recruited as the final study population. The study was approved by
the Ethics Committee of Tampere University Hospital and written
informed consent was obtained from patients or first-degree
relatives. All subjects were treated with an empiric antibiotic
regimen, and when necessary antimicrobial treatment was
changed according to culture results. In all patients the causative
organism proved susceptible to the first empiric antibiotic
treatment selected on admission.
Underlying conditions and chronic diseases
Chronic diseases and sources of bacteremia were registered.
Alcoholabusewasdefinedasconsumptionof300 gabsolutealcohol
per week or a known social or medical problem due to alcohol use.
Patients were defined as current smokers and nonsmokers, i.e. those
who had never smoked or had stopped smoking. Calculation of
body mass index (BMI, kg/m
2) was based on weight and height as
reported by the patient on admission. Patients weredefined as obese
if their BMI was $30 kg/m
2. McCabe classification [14] was used
to determine the severity of underlying diseases.
Clinical data and laboratory tests
Clinical data and laboratory findings were registered on
admission and during 6 consecutive days. Alterations in mental
status were evaluated on the Glasgow Coma Scale (GCS) and
possible mechanical ventilation and the need for intensive care
unit (ICU) treatment were recorded. Mean arterial pressure
(MAP) ((systolic+2 x diastolic blood pressure)/3) and SOFA
score (sequential organ failure assessment) [15] were calculated.
The maximum SOFA score (days 0–6) for every patient was
used in analysis. Disease severity was assessed by SOFA score,
severe disease being defined as a score $4. Laboratory tests
included plasma C-reactive protein (CRP, mg/l), blood platelets
(610
9/l), plasma bilirubin (mmol/l), plasma creatinine level
(mmol/l) and blood leucocyte count (610
9/l). We have recently
published a study on the prognostic value of high kynurenine
(kyn) to tryptophan (trp) concentration ratio detected on days 1
to 4, reflecting indoleamine 2,3 dioxygenase (IDO) activity [16].
Kyn and trp values had been examined by high-performance
liquid chromatography (HPLC) [16]. The optimal cut-off for
maximum IDO activity in predicting fatal disease had been
evaluated using the receiver operating characteristic curve
Table 1. Characteristics of the study population.
Characteristic
Causative organism
S. aureus 32 (24%)
Str. pneumoniae 37 (28%)
B- hemolytic streptococcus 22 (17%)
E. coli 41 (31%)
Demographic features and underlying diseases
Age, median (range) 62 (16–93 years)
Gender (female/male) 62/70
Cancer (solid or hematological) 23 (17%)
At least one chronic disease 107 (81%)
Alcohol abuse 21 (16%)
Diabetes mellitus (type 1 or 2) 33 (25%)
BMI (kg/m
2), median (range)
a 26 (15–39)
Bacteremia focus
Skin 33 (25%)
Urinary 29 (22%)
Lung 33 (25%)
Osteomyelitis/spondylitis 13 (10%)
Other or unknown focus 41 (31%)
aBMI data available on 101 patients.
doi:10.1371/journal.pone.0021700.t001
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days after a positive blood culture (d-14 and d-30 case fatality).
Samples were available for altogether 132 patients on days 1–4
after the positive blood culture. Multiple samplings in the same
patient were always performed on separate days. Samples for cf-
DNA determinations were available on day 1–2 (1–2 days after the
blood culture was taken): 34 patients, on day 3: 81 patients and on
day 4: 104 patients. In addition, 121 patients gave a sample on day
5–17 (5–17 days after blood culture) and 89 gave a sample on
recovery (.25 days after positive blood culture). The maximum
values for cf-DNA in every patient measured during 1–4 days after
positive blood culture were determined. Since patient recruitment
was based on blood culture, which only became positive the
following day, no samples for cf-DNA were available on day 0
(blood culture day).
Quantification of total plasma cf-DNA
The amount of total cf-DNA was determined directly in
plasma without any purification step, using the Quant-iT
TM
high-sensitivity DNA assay kit and a QubitH fluorometer
(Invitrogen, Carlsbad, CA, USA) following the manufacturer’s
instructions. The assessed intra-day variation coefficients at
the mean cf-DNA levels of 0.734 mg/ml, 1.377 mg/ml and
4.954 mg/ml were 1.8%, 4.3% and 1.7%, respectively. The
corresponding inter-day variation coefficients were 3.8%, 5.0%
and 3.2%.
Extraction and qualitative analysis of cf-DNA
Qualitative analysis of cf-DNA was performed in randomly
selected (n=16) cases (n=8 survivors and n=8 non-survivors).
Plasma cf-DNA was extracted using the NucleoSpinH PlasmaXS Kit
(MACHEREY-NAGEL GmbH & Co., Du ¨ren,Germany),designed
for isolation of low-molecular-weight (50–1000 bp) cf-DNA. Cf-DNA
isolation was performed according to the manufacturer’s instructions
following the high-sensitivity protocol. Extracted cf-DNA samples
were stored at -70uC until further analyses.
Extracted cf-DNA samples were analyzed with the High
Sensitivity DNA assay kit and an Agilent 2100 Bioanalyzer
equipped with Expert 2100 software according to the manufac-
turer’s instructions (Agilent Technologies Inc., Santa Clara, CA).
Table 2. Plasma cell free DNA (cf-DNA) values in patients with bacteremia stratified by various demographic features, underlying
conditions and causative organism.
Character Maximum cf-DNA (ug/ml) 1 to 4 days after blood culture p-value
Stratification by underlying factors
Factor present, median (quartiles) Factor absent, median (quartiles)
Age over 60 years 1.28 (1.11–1.72) 1.31 (1.15–1.65) 0.796
Male 1.35 (1.19–1.87) 1.24 (1.09–1.41) 0.031
Obesity (BMI$30 kg/m2)
a 1.35 (1.21–2.00) 1.27 (1.11–1.61) 0.252
Current smoking
b 1.41 (1.18–2.00) 1.27 (1.11–1.46) 0.096
Alcohol abuse 1.61 (1.31–2.69) 1.26 (1.10–1.53) 0.001
Diabetes mellitus type 1 or 2 1.33 (1.05–1.80) 1.28 (1.15–1.66) 0.787
Cancer 1.29 (1.07–1.66) 1.28 (1.14–1.71) 0.760
McCabe class II or III
c 1.36 (1.11–1.76) 1.38 (1.13–1.68) 0.656
Causative organism
S. aureus 1.40 (1.28–1.96)
Str. pneumoniae 1.28 (1.14–1.71) 0.011
d
B-hemolytic streptococcus 1.19 (1.02–1.62)
E. coli 1.24 (1.09–1.45)
aBMI data available on 101 patients,
bsmoking data available on 120 patients,
cultimately or rapidly fatal disease,
dvalue indicates the difference in cf-DNA values between groups of patients stratified by different causative organism.
doi:10.1371/journal.pone.0021700.t002
Table 3. Plasma cell free DNA concentration during days 1 to 4 after blood culture in relation to bacteremia outcome.
Days after blood culture Plasma cell free DNA (ug/ml), median (quartiles) p-value
Nonsurvivors n=18 Survivors n=118
Day 1–2 1.36 (1.31–1.81) 1.27 (1.10–1.44) 0.166
Day 3 1.97 (1.59–2.38) 1.20 (1.06–1.37) ,0.001
Day 4 1.91 (1.49–2.70) 1.25 (1.11–1.38) ,0.001
Maximum value (days 1 to 4) 2.03 (1.57–2.68) 1.26 (1.11–1.47) ,0.001
acf-DNA values available on 34 patients on day 1–2, 81 patients on day 3, 104 patients on day 4 and 132 patients on day 1 to 4 (maximum value).
doi:10.1371/journal.pone.0021700.t003
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lab-on-a-chip technology to perform gel electrophoresis; nucleic
acids are separated analogously to capillary electrophoresis and
normalized to a ladder and two DNA markers, whereafter the
software automatically calculates the size of each band. For each
sample, the appearance and intensity of low-molecular-weight cf-
DNA was estimated visually and graded as follows: 1=no visible
cf-DNA or weak intensity, 2=intermediate intensity, 3=strong
intensity. The researcher responsible for analyzing and grading the
cf-DNA samples was blinded to the outcome of the patient.
sFas and Fas ligand measurements
Human soluble Fas (sFas) and human Fas ligand concentrations in
plasma were determined using commercial quantitative sandwich
enzyme immunoassays (QuantikineH, R&D Systems Inc., Minneap-
olis, MN, USA.
Statistical analysis
An SPSS package (version 7.5 and version 10) was used for
statistical analyses and a two-sided p-value ,0.05 was taken as cut-
off for statistical significance. Categorical data were analyzed by
X
2 test or Fishers exact test when appropriate, nonparametric data
by Mann-Whitney U-test or Kruskal-Wallis test. A logistic
regression model was used to study the independent effect of high
cf-DNA concentration on mortality models adjusted for potential
confounders. Odds ratios (ORs) were expressed with their 95%
confidence intervals (CI). The survival curve was calculated using
the Kaplan-Meier method and survival differences between groups
were compared using the log rank test. The accuracy of maximum
cf-DNA in predicting case fatality was evaluated using ROC curves
[17]. In this method, a test which is perfect has 100% sensitivity and
no false-positives (1-specificity=0) and will have an area under the
curve(AUC)of1.0,whereasa testofnodiagnosticvaluewouldhave
anAUCof0.5.Youdenindexwiththehighestsumofsensitivityand
specificity (sensitivity + (1-specificity)) was used to select optimal cut
off for analysis. Spearman’s Rank correlation test was used to test
the direction and strength of the relationship between two variables.
The total amount of cf-DNA (Quant-iT
TM assay) was correlated
withthe graded intensityof the low-molecular-weight cf-DNA,sFas,
Fas ligand and kyn/trp ratio using Spearman’s r.
Results
Baseline characteristics of bacteremia patients are shown in
Table 1. The median plasma cf-DNA value in the acute phase
(maximum value 1 to 4 days after blood culture) was 1.29 mg/ml
(quartiles 1.13–1.69 mg/ml) and 1.19 mg/ml (quartiles 1.03–1.43)
on days 5–17 after blood culture. The median value .25 days after
blood culture was 0.88 mg/ml (quartiles 0.78–0.98 mg/ml). cf-DNA
values in patients with bacteremia stratified by demographics,
underlying conditionsandcausativeorganismareshown inTable 2.
Of chronic conditions, alcohol abusers had higher cf-DNA values
compared to patients without the history of alcohol abuse (Table 2).
cf-DNA and outcome of bacteremia
Median cf-DNA values were significantly higher in nonsurvivors
compared to survivors on days 3 (1.97 vs 1.20 ug/ml, p,0.001)
Figure 1. cf-DNA line plot diagram. A Line plot diagram showing
cell free DNA (cf-DNA) concentration detected on days 1–4, 5 to 17 days
and .25 days after blood culture in nonsurvivors (black plots) and in
survivors (open plots).
doi:10.1371/journal.pone.0021700.g001
Figure 2. cf-DNA ROC curve. Receiver operating characteristic (ROC)
curve for maximal plasma cell free DNA (cf-DNA) concentration
detected on days 1–4 after positive blood culture in relation to case
fatality in bacteremia patients.
doi:10.1371/journal.pone.0021700.g002
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diagnosis (blood culture day) (Table 3). Maximum cf-DNA values
on days 1 to 4 after the initial diagnosis (blood culture day) were
significantly higher in nonsurvivors compared to survivors (median
values 2.03 and 1.26, p,0.001) (Figure 1).
Theoptimalcut-offvalueforthemaximumcf-DNAvaluesondays
1–4 in predicting fatal disease was estimated using ROC curve,
illustratedinFigure2.Thecf-DNAvalueatacut-offlevelof1.52 ug/
ml showed a sensitivity of 83% and a specificity of 79% in detecting
fatal disease, and this cut-off point was used to classify patients into
those with high or low cf-DNA value. High cf-DNA values were
associatedwithseveralendpointsindicativeofseveredisease(Table4).
Figure 3 shows the cumulative 30-d survival in bacteremia patients
with maximum plasma cf-DNA level (1–4 days after blood culture)
.1.52 ug/ml compared to those with #1.52 ug/ml.
Qualitative analysis of cf-DNA revealed that cf-DNA displays a
predominating low-molecular- weight cf-DNA band (150–200 bp)
in nonsurvivors corresponding to the size of apoptotic nucleosomal
DNA (Figure 4). Spearman9s correlation test showed a significant
positive correlation between the acute phase (1 to 4 days after
blood culture) cf-DNA level and visual grading of apoptotic band
intensity (R=0.822, p,0.001)(Table 5). A weak, albeit significant,
positive correlation between cf-DNA and sFas (ug/ml) was
documented (Table 5).
The independent effect of high (.1.52 ug/ml) maximum cf-
DNA value on case fatality was studied in a logistic regression
model adjusted for potential confounders. The following grouping
variables have previously been shown to be associated with case
fatality in a univariate model in this material: obesity, smoking,
alcohol abuse and high SOFA score ($4)[16,18]. High cf-DNA
detected on days 1–4 after blood culture retained its significance in
the logistic regression model in all combinations. High maximun
Table 4. Clinical disease severity of patients stratified by maximum plasma cell free DNA (cf-DNA) value (1 to 4 days after blood
culture).
Clinical disease severity
High cf-DNA
(.1.52 ug/ml) N=39
Low cf-DNA
(#1.52 ug/ml) n=93 OR (95% CI) p-value
Grouping variables
Died (d-30 case fatality) 15 (39%) 3 (3%) 18.8 (5.0–70.1) ,0.001
Died (d-14 case fatality) 11 (28%) 1 (1%) 36.1 (4.5–292.3) ,0.001
Hypotensive 27 (69%) 25 (27%) 6.1 (2.7–13.9) ,0.001
Needed ICU stay
a 24 (62%) 18 (19%) 6.7 (2.9–15.2) ,0.001
Needed vasopressives 21 (54%) 5 (5%) 20.5 (6.8–61.6) ,0.001
Lowered Glasgow coma scale (,15) 26 (67%) 27 (29%) 4.9 (2.2–10.9) ,0.001
Needed mechanical ventilation 15 (39%) 5 (5%) 11.0 (3.6–33.3) ,0.001
Highest SOFA score$4
b 30 (77%) 25 (27%) 9.1 (3.8–21.7) ,0.001
Continuous variables
Minimum MAP
c (mmHg), median (quartiles) 62 (52–73) 77 (68–90) ,0.001
Maximum SOFA score, median (quartiles) 9 (4–13) 2 (0–4) ,0.001
Maximum bilirubin level, median (quartiles) 33 (17–81) 16 (12–25) ,0.001
Maximum creatinine level, median (quartiles) 159 (95–213) 96 (73–167) 0.005
Median neutrophil count (610
9/l) (quartiles) (n=112) 10.3 (7.4–13.3) 6.8 (3.9–9.5) 0.002
Maximum C-reactive protein (mg/l) 279 (204–372) 213 (150–329) 0.025
Minimum platelet count (610
9/l), median (quartiles) 86 (33–165) 181 (116–241) ,0.001
aintensive care unit,
bsequential organ failure assessment,
cmean arterial pressure, $continuous variable (OR and CI cannot be applied).
doi:10.1371/journal.pone.0021700.t004
Figure 3. cf-DNA and survival curve. Cumulative 30-d survival in
bacteremia patients with maximum plasma cell free DNA (cf-DNA)
.1.52 ug/ml compared to those with cf-DNA #1.52 ug/ml. The cut off
value of 1.52 ug/ml was chosen using ROC curve. The survival curve
was calculated using the Kaplan-Meier method, and survival differences
between groups were compared by log-rank test.
doi:10.1371/journal.pone.0021700.g003
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at a time in the model, as there were only 18 patients who died. cf-
DNA predicted outcome independently of alcohol abuse, gender
and causative organism (data not shown). Obesity and high SOFA
score ($4) also remained independent factors associated with case
fatality when studied together with high cf-DNA.
Figure 4. Qualitive cf-DNA analysis. Qualitative analysis of plasma cf-DNA in 8 bacteremia survivors (panel A) and 8 non-survivors (panel B) after
NucleoSpinH Plasma XS kit extraction. Analyses were performed with Agilent’s High Sensitivity Lab-on-a-chip DNA assay. Green lines indicate the low-
weight (35 bp) DNA marker and purple lines the high- weight (10 380 bp) DNA marker. TP 1=time point 1 (1 to 4 days after blood culture), TP 2=
time point 2 (5 to 17 days after blood culture), TP 3=time point 3 (recovery, .25 days after blood culture). The intensity of the low-molecular-weight
cf-DNA band was graded as follows: 1=no visible cf-DNA or weak intensity, 2=intermediate intensity, 3=strong intensity. Abbreviations; bp= base
pairs, TP=time point.
doi:10.1371/journal.pone.0021700.g004
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The present results show that the plasma cell free DNA
concentration is significantly higher in bacteremia nonsurvivors
compared to survivors. Qualitative analysis of cf-DNA revealed
that cf-DNA displays a predominating low-molecular-weight cf-
DNA band (150–200 bp) in nonsurvivors corresponding to the size
of apoptotic nucleosomal DNA.
The present findings are in accord with those of previous studies
showing increased levels of plasma cf-DNA in septic patients. The
present study provides novel evidence regarding the origin of cf-
DNA from apoptotic cells. This finding is line with the suggestion
that severe sepsis is characterized by apoptotic cell death and that
this phenomenon plays a pivotal role in fatal cases [1]. Apoptosis is
a form of cell death characterized by cytoplasmic condensation,
compaction of nuclear chromatin and nuclear fragmentation,
resulting in a characteristic pattern of DNA laddering in agarose
gel electrophoresis. Recent studies indicate upregulation of the
pro-apoptotic genes BID and FAS in septic shock patients [19].
Animal studies suggest that blocking apoptosis may constitute an
intriguing opportunity to improve outcomes in sepsis [1]. Caspase
inhibition is a novel sepsis therapy in preclinical development,
based on blocking apoptosis [1].
Circulating DNA in plasma is protein-bound (nucleosomal)
DNA. Quantification of circulating DNA can be performed by
real-time quantitative PCR or immunological methods such as
ELISA [11]. Circulating DNA is known to be highly fragmented
and low in concentration, which creates difficulties in its
purification. In the present study, the amount of total cf-DNA
was determined directly in plasma without any purification step
using a high-sensitivity DNA assay kit and a fluorometric method.
As purification was not needed for quantification, this approach
constitutes a rapid and cheap means of detecting free DNA in
plasma. In oncology, cf-DNA has been shown to be useful in
staging, identifying disease progression and response to therapy in
patients with cancer [8]. CRP has been shown to be of limited
prognostic value in the present cohort [16]. Thus, cf-DNA
measurement may be useful in clinical use and stratification of
patients with distinct bacteremia outcomes.
Previous studies have studied cf-DNA concentrations in sepsis
expecially in ICU settings [9,10]. Saukkonen and associates
showed that cf-DNA was an independent predictor of ICU but not
in-hospital mortality in severe sepsis and septic shock [9]. Several
studies have shown cf-DNA to predict outcome in all-cause ICU
patients [10,13]. One study showed that cf-DNA predicted the
presence of infection in febrile patients and that cf-DNA also
predicted outcome [12]. Rhodes and associates showed that high
plasma cf-DNA predicted the development of sepsis or septic
shock in critically ill patients [10]. Studies in cancer patients
indicate that circulating DNA originates from apoptotic or
necrotic cells [6], reflecting the extent of cellular damage.
Supporting such a conception, hypothesis, cf-DNA has frequently
been observed with a nucleosomal (150–200 base pairs in length)
or a ladder-like appearance [6,20]. To the best of our knowledge,
the present study shows for the first time that cf-DNA expresses
apoptotic fragmentation in bacteremia nonsurvivors. The mech-
anisms underlying apoptotic cell death in sepsis remain elusive.
Imbalance between oxygen delivery and consumption resulting in
anaerobic glycolysis and lactate production are central features in
severe septic infection. This may lead to oxygen deprivation,
endothelial cell damage and subsequent apoptotic cell death.
Interestingly, cf-DNA levels were higher in males than in females
in the acute phase. Male sex did not however predict case fatality
and cf-DNA remained a significant factor associated with case
fatality after adjusting for patient gender. We demonstrate a
significant difference in cf-DNA values between groups of patients
stratified by different causative agents. Bacteremias caused by
different organisms have been shown to have different case fatality
rates and evidence suggests that the host response may differ
depending on the type of microbial pathogen [21].
We showed a weak, albeit significant, correlation with the
indirect marker of apoptosis, sFas and with kynurenine to
tryptophan ratio reflecting IDO activity. A correlation with sFas
and cf-DNA is in line with the fact that the progression of
apoptosis is regulated by intracellular signaling pathways after
binding of a death-specific receptor (fas) to its ligand (fasl) [4]. We
recently published a study on the prognostic value of high IDO
concentration ratio and showed an association between high IDO
and case fatality in bacteremia [16]. IDO is an enzyme which
degrades the essential amino acid tryptophan to kynurenine, with
subsequent suppression of T-cells [22]. IDO has been shown to
have a central role in the regulation of blood pressure in sepsis
[23]. It remains to be established whether IDO contributes to
immune system paralysis in bacteremia and sepsis.
Some limitations have to be considered here. Due to the study
design, the potential causal role of cf-DNA in fatal cases could not
be adressed. Previous studies indicate that precisely lymphocytes
are prone to apoptotic cell death in severe sepsis. Apoptosis has
been shown to take place both in the gastrointestinal tract
epithelium and in circulating blood lymphocytes. Further work is
needed to investigate the intracellular sources of plasma DNA.
No control group was used in the present study, which constitutes
a limitation. Controls from critically ill patients with no
bacteremia or sepsis would have been important to indicate cf-
DNA values in these patients. Previous studies suggest that
infection per se is associated with higher cell-free plasma DNA
concentrations compared to non-infectious conditions [12,13].
However, the present findings consistently showed median cf-
DNA levels to be higher in acute illness than in the convalescence
phase. We studied most common bacterial pathogens encoun-
tered in the case of community-acquired bacteremia. The present
findings can be generalized to bacteremias caused by S. aureus, E.
coli, ß-hemolytic streptococcus and Str. Pneumoniae. Thus, the
significance of cf-DNA as a predictor of case fatality should be
studied also in bacteremias caused by other culprit organisms in
the future.
In conclusion, it was established here that plasma cf-DNA
concentrations are significantly increased in bacteremia patients
Table 5. Spearman9s test correlation between cf-DNA level
and C-reactive protein (CRP), soluble Fas (sFas), Fas ligand
(FasL), kynurenine to tryptophan ratio (kyn/trp) and visually
graded band intensity in gel electrophoresis.
cf-DNA
Test
Correlation
coefficient p-value
C-reactive protein (mg/l) 0.217 0.012
sFas (ug/ml) (n=132) 0.383 ,0.001
Fas ligand (ug/ml) (n=132) 20.183 0.036
Kyn/trp ratio (mmol/mmol)(n=132) 0.400 ,0.001
Visually graded apoptotic 200 bp band
intensity (I–IV) (n=16)
0.822 ,0.001
Acute phase values (during days 1 to 4 after blood culture) were studied.
doi:10.1371/journal.pone.0021700.t005
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fragmentation bands. These findings support the conception that
apoptosis plays a pivotal role in severe bacteremic infection. The
development of therapeutic interventions targeted to apoptosis
pathways may be a key element leading to improved patient
outcomes. cf-DNA can be used as a non-invasive, rapid, sensitive
and accurate marker of severe bacteremia.
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